Qi Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qi Meng has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Jun Lin
Chinese Academy of Sciences
8 shared publications - Binbin Ding
Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun Jilin China
7 shared publications Hao Chen
Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry
6 shared publications- Ping'AN Ma
Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun Jilin China
6 shared publications Jia Tan
Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry
5 shared publicationsJing Li
State Key Laboratory of Rare Earth Resource Utilization
5 shared publications
Latest Publications
- Open Access
- 2 January 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (2) , 2225-2238
Albumin Nanoparticles Co-Loaded with Dual Drugs for Enhanced Ferroptosis-Based Cancer Therapy through Modulating Cholesterol Metabolism
Ferroptosis is a form of regulated cell death driven by lipid peroxidation, in which the diffusion of lipid peroxidation substrates on the plasma membrane is hindered by lipid rafts, thereby inhibiting the ferroptosis process. Lipid rafts are microdomains composed of cholesterol, sphingolipids, and specific proteins. Notably, cholesterol acyltransferase sterol O-acyltransferase 1 (SOAT1) is highly expressed in various malignant tumors, where it promotes tumor cell growth by enhancing intracellular cholesterol storage. To alleviate the obstruction of ferroptosis progression by lipid rafts, we developed human serum albumin nanoparticles (HSA@Aur&Ava) for codelivery of the SOAT1 inhibitor avasimibe (Ava) and the ferroptosis inducer auranofin (Aur). Ava indirectly disrupts the structure of lipid rafts by blocking cholesterol esterification, while Aur induces ferroptosis by inhibiting thioredoxin reductase. The synergistic effect of these two agents enhances the accumulation of lipid peroxides and the occurrence of ferroptosis. Additionally, tumor cells release damage-associated molecular patterns (DAMPs), which enhance the maturation of dendritic cells (DCs) and further recruit CD8+ T cells, thereby activating the immune response. The nanoparticles significantly inhibit tumor progression through chemotherapy and immunotherapy, offering an insight for highly effective antitumor strategies from the standpoint of cholesterol metabolism.
- 2 January 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (2) , 2225-2238
Open AccessAlbumin Nanoparticles Co-Loaded with Dual Drugs for Enhanced Ferroptosis-Based Cancer Therapy through Modulating Cholesterol Metabolism
Ferroptosis is a form of regulated cell death driven by lipid peroxidation, in which the diffusion of lipid peroxidation substrates on the plasma membrane is hindered by lipid rafts, thereby inhibiting the ferroptosis process. Lipid rafts are microdomains composed of cholesterol, sphingolipids, and specific proteins. Notably, cholesterol acyltransferase sterol O-acyltransferase 1 (SOAT1) is highly expressed in various malignant tumors, where it promotes tumor cell growth by enhancing intracellular cholesterol storage. To alleviate the obstruction of ferroptosis progression by lipid rafts, we developed human serum albumin nanoparticles (HSA@Aur&Ava) for codelivery of the SOAT1 inhibitor avasimibe (Ava) and the ferroptosis inducer auranofin (Aur). Ava indirectly disrupts the structure of lipid rafts by blocking cholesterol esterification, while Aur induces ferroptosis by inhibiting thioredoxin reductase. The synergistic effect of these two agents enhances the accumulation of lipid peroxides and the occurrence of ferroptosis. Additionally, tumor cells release damage-associated molecular patterns (DAMPs), which enhance the maturation of dendritic cells (DCs) and further recruit CD8+ T cells, thereby activating the immune response. The nanoparticles significantly inhibit tumor progression through chemotherapy and immunotherapy, offering an insight for highly effective antitumor strategies from the standpoint of cholesterol metabolism.
- 11 June 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (25) , 10053-10062
Oxamate Nanoparticles for Enhanced Tumor Immunotherapy through Blocking Glycolysis Metabolism and Inducing Pyroptosis
Tumor metabolic reprogramming, particularly the Warburg effect, is crucial for rapid tumor growth and immune evasion. Lactate dehydrogenase A (LDHA), a key enzyme in tumor aerobic glycolysis, is overexpressed in tumors and is considered an effective therapeutic target. Sodium oxamate (SOM) is a classic LDHA inhibitor, but its poor cell permeability, low tumor killing effect, and ineffective immune activation limit its application. Herein, SOM nanoparticles (NPs) were prepared via a thin-film hydration method for amplified cancer immunotherapy. SOM NPs are efficiently taken up by tumor cells through endocytosis, releasing NH2COCOO- and Na+ ions, which cause osmotic pressure and oxidative stress, activating pyroptosis and immunogenic cell death (ICD) to initiate the immune response. Simultaneously, NH2COCOO- blocks glycolysis of tumor cells, resulting in inhibiting the proliferation, migration, and invasion and alleviating immunosuppression. This work will facilitate the application of SOM in tumor therapy and provide a new paradigm for glycolytic metabolism and pyroptosis-mediated tumor treatment.
- 11 June 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (25) , 10053-10062
Oxamate Nanoparticles for Enhanced Tumor Immunotherapy through Blocking Glycolysis Metabolism and Inducing Pyroptosis
Tumor metabolic reprogramming, particularly the Warburg effect, is crucial for rapid tumor growth and immune evasion. Lactate dehydrogenase A (LDHA), a key enzyme in tumor aerobic glycolysis, is overexpressed in tumors and is considered an effective therapeutic target. Sodium oxamate (SOM) is a classic LDHA inhibitor, but its poor cell permeability, low tumor killing effect, and ineffective immune activation limit its application. Herein, SOM nanoparticles (NPs) were prepared via a thin-film hydration method for amplified cancer immunotherapy. SOM NPs are efficiently taken up by tumor cells through endocytosis, releasing NH2COCOO- and Na+ ions, which cause osmotic pressure and oxidative stress, activating pyroptosis and immunogenic cell death (ICD) to initiate the immune response. Simultaneously, NH2COCOO- blocks glycolysis of tumor cells, resulting in inhibiting the proliferation, migration, and invasion and alleviating immunosuppression. This work will facilitate the application of SOM in tumor therapy and provide a new paradigm for glycolytic metabolism and pyroptosis-mediated tumor treatment.
- 3 April 2025
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 58 (8) , 1210-1223
Inorganic Nanobiomaterials Boost Tumor Immunotherapy: Strategies and Applications
ConspectusTumor immunotherapy, as a new antitumor method to fight cancer by activating or enhancing the body's own immune system, has been extensively studied and applied in clinical practice. However, as an extremely complex system, tumor heterogeneity and complex immunosuppressive tumor microenvironment (TME) lead to poor immune response rate or secondary drug resistance. The advent of nanotechnology has ushered in a new era for immunotherapy. In particular, inorganic nanomaterials, with their unique physicochemical properties and excellent biocompatibility, are becoming an important tool for enhancing immunotherapy. Inorganic nanomaterials can be used as carriers for immune agents, improving drug delivery efficiency and thereby reducing systemic immunotoxicity and enhancing immune responses. Inorganic nanomaterials also trigger tumor immunogenic cell death (ICD), stimulate antitumor immune responses, and alleviate immunosuppressive TME by increasing oxygen levels, modulating metabolic pathways, and altering the secretion of immunosuppressive cytokines. The synergistic integration of inorganic nanomaterials with immunotherapy adeptly navigates around the constraints of conventional treatments, reducing side effects while concurrently augmenting therapeutic efficacy. In this review, we summarize our recent efforts in the design and synthesis of inorganic nanobiomaterials to enhance the efficacy of tumor immunotherapy. These nanomaterials achieve the desired immune efficacy mainly through four strategies, including inducing ICD, developing tumor nanovaccines, activating pyroptosis, and regulating tumor metabolism, providing beneficial implications for tumor immunotherapy. For one thing, due to the deficiency of ICD effect in single therapy, we mainly developed nanocatalysts that integrate multiple therapeutic functions to play a catalytic role in TME, converting tumor substances or metabolites into therapeutic products in situ, and further enhancing ICD. For another, in order to solve the problems of low antigen loading and therapeutic efficiency of existing adjuvants, several novel multifunctional nanoadjuvants were prepared, which combine high antigen loading and multimode therapeutic function in one, and achieve efficient immune activation. Moreover, to attain strong inflammatory responses and immunogenicity, we engineer pyroptosis adjuvants that selectively induce tumor cell pyroptosis by enhancing intracellular oxidative stress or ion overload. Finally, to reverse the immunosuppressive microenvironment, we developed nanoplatforms that target tumor metabolism, altering the levels of nutrients and metabolites in tumor such as glucose, lactic acid, citric acid, and tryptophan to effectively alter the TME, thereby activating and enhancing the body's immune response. The implementation of these strategies not only improves the therapeutic effect but also reduces the side effects and provides valuable insights and references for the development of novel nanomaterials to assist immunotherapy.
- 3 April 2025
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 58 (8) , 1210-1223
Inorganic Nanobiomaterials Boost Tumor Immunotherapy: Strategies and Applications
ConspectusTumor immunotherapy, as a new antitumor method to fight cancer by activating or enhancing the body's own immune system, has been extensively studied and applied in clinical practice. However, as an extremely complex system, tumor heterogeneity and complex immunosuppressive tumor microenvironment (TME) lead to poor immune response rate or secondary drug resistance. The advent of nanotechnology has ushered in a new era for immunotherapy. In particular, inorganic nanomaterials, with their unique physicochemical properties and excellent biocompatibility, are becoming an important tool for enhancing immunotherapy. Inorganic nanomaterials can be used as carriers for immune agents, improving drug delivery efficiency and thereby reducing systemic immunotoxicity and enhancing immune responses. Inorganic nanomaterials also trigger tumor immunogenic cell death (ICD), stimulate antitumor immune responses, and alleviate immunosuppressive TME by increasing oxygen levels, modulating metabolic pathways, and altering the secretion of immunosuppressive cytokines. The synergistic integration of inorganic nanomaterials with immunotherapy adeptly navigates around the constraints of conventional treatments, reducing side effects while concurrently augmenting therapeutic efficacy. In this review, we summarize our recent efforts in the design and synthesis of inorganic nanobiomaterials to enhance the efficacy of tumor immunotherapy. These nanomaterials achieve the desired immune efficacy mainly through four strategies, including inducing ICD, developing tumor nanovaccines, activating pyroptosis, and regulating tumor metabolism, providing beneficial implications for tumor immunotherapy. For one thing, due to the deficiency of ICD effect in single therapy, we mainly developed nanocatalysts that integrate multiple therapeutic functions to play a catalytic role in TME, converting tumor substances or metabolites into therapeutic products in situ, and further enhancing ICD. For another, in order to solve the problems of low antigen loading and therapeutic efficiency of existing adjuvants, several novel multifunctional nanoadjuvants were prepared, which combine high antigen loading and multimode therapeutic function in one, and achieve efficient immune activation. Moreover, to attain strong inflammatory responses and immunogenicity, we engineer pyroptosis adjuvants that selectively induce tumor cell pyroptosis by enhancing intracellular oxidative stress or ion overload. Finally, to reverse the immunosuppressive microenvironment, we developed nanoplatforms that target tumor metabolism, altering the levels of nutrients and metabolites in tumor such as glucose, lactic acid, citric acid, and tryptophan to effectively alter the TME, thereby activating and enhancing the body's immune response. The implementation of these strategies not only improves the therapeutic effect but also reduces the side effects and provides valuable insights and references for the development of novel nanomaterials to assist immunotherapy.
- 20 August 2024
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 6 (9) , 4302-4311
Dual Regulation of Energy/Electron Transfer in MOF@COP Heterojunctions through Ingenious Molecular Engineering for Enhanced Sonodynamic Cancer Therapy
- 20 August 2024
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 6 (9) , 4302-4311
Dual Regulation of Energy/Electron Transfer in MOF@COP Heterojunctions through Ingenious Molecular Engineering for Enhanced Sonodynamic Cancer Therapy
- Top Cited Papers
- 29 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (31) , 21496-21508
Sulfur-Vacancy-Engineered Two-Dimensional Cu@SnS2–x Nanosheets Constructed via Heterovalent Substitution for High-Efficiency Piezocatalytic Tumor Therapy
Ultrasound (US)-mediated piezocatalytic tumor therapy has attracted much attention due to its notable tissue-penetration capabilities, noninvasiveness, and low oxygen dependency. Nevertheless, the efficiency of piezocatalytic therapy is limited due to an inadequate piezoelectric response, low separation of electron-hole (e--h+) pairs, and complex tumor microenvironment (TME). Herein, an ultrathin two-dimensional (2D) sulfur-vacancy-engineered (Sv-engineered) Cu@SnS2-x nanosheet (NS) with an enhanced piezoelectric effect was constructed via the heterovalent substitution strategy of Sn4+ by Cu2+. The introduction of Cu2+ ion not only causes changes in the crystal structure to increase polarization but also generates rich Sv to decrease band gap from 2.16 to 1.62 eV and inhibit e--h+ pairs recombination, collectively leading to the highly efficient generation of reactive oxygen species under US irradiation. Moreover, Cu@SnS2-x shows US-enhanced TME-responsive Fenton-like catalytic activity and glutathione depletion ability, further aggravating the oxidative stress. Both in vitro and in vivo results prove that the Sv-engineered Cu@SnS2-x NSs can significantly kill tumor cells and achieve high-efficiency piezocatalytic tumor therapy in a biocompatible manner. Overall, this study provides a new avenue for sonocatalytic therapy and broadens the application of 2D piezoelectric materials.
- 29 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (31) , 21496-21508
Top Cited PapersSulfur-Vacancy-Engineered Two-Dimensional Cu@SnS2–x Nanosheets Constructed via Heterovalent Substitution for High-Efficiency Piezocatalytic Tumor Therapy
Ultrasound (US)-mediated piezocatalytic tumor therapy has attracted much attention due to its notable tissue-penetration capabilities, noninvasiveness, and low oxygen dependency. Nevertheless, the efficiency of piezocatalytic therapy is limited due to an inadequate piezoelectric response, low separation of electron-hole (e--h+) pairs, and complex tumor microenvironment (TME). Herein, an ultrathin two-dimensional (2D) sulfur-vacancy-engineered (Sv-engineered) Cu@SnS2-x nanosheet (NS) with an enhanced piezoelectric effect was constructed via the heterovalent substitution strategy of Sn4+ by Cu2+. The introduction of Cu2+ ion not only causes changes in the crystal structure to increase polarization but also generates rich Sv to decrease band gap from 2.16 to 1.62 eV and inhibit e--h+ pairs recombination, collectively leading to the highly efficient generation of reactive oxygen species under US irradiation. Moreover, Cu@SnS2-x shows US-enhanced TME-responsive Fenton-like catalytic activity and glutathione depletion ability, further aggravating the oxidative stress. Both in vitro and in vivo results prove that the Sv-engineered Cu@SnS2-x NSs can significantly kill tumor cells and achieve high-efficiency piezocatalytic tumor therapy in a biocompatible manner. Overall, this study provides a new avenue for sonocatalytic therapy and broadens the application of 2D piezoelectric materials.
- 4 July 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 242, 114076
Pt(IV) complexes loaded hollow copper sulfide nanoparticles for tumor chemo/photothermal/photodynamic therapy
- 4 July 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 242, 114076
Pt(IV) complexes loaded hollow copper sulfide nanoparticles for tumor chemo/photothermal/photodynamic therapy
- 26 February 2024
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 6 (4) , 1103-1111
Cysteine Depletion-Initiated Redox Imbalance Evokes Ferroptosis and Pyroptosis for Enhanced Pancreatic Cancer Therapy
- 26 February 2024
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 6 (4) , 1103-1111
Cysteine Depletion-Initiated Redox Imbalance Evokes Ferroptosis and Pyroptosis for Enhanced Pancreatic Cancer Therapy
- 1 November 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (21) , 21553-21566
π Bridge Engineering-Boosted Dual Enhancement of Type-I Photodynamic and Photothermal Performance for Mitochondria-Targeting Multimodal Phototheranostics of Tumor
Designing mitochondria-targeting phototheranostic agents (PTAs), which can simultaneously possess exceptional and balanced type-I photodynamic therapy (PDT) and photothermal therapy (PTT) performance, still remains challenging. Herein, benzene, furan, and thiophene were utilized as π bridges to develop multifunctional PTAs. STB with thiophene as a π bridge, in particular, benefiting from stronger donor-accepter (D-A) interactions, reduced the singlet-triplet energy gap (ΔES1-T1), allowed more free intramolecular rotation, and exhibited outstanding near-infrared (NIR) emission, effective type-I reactive oxygen species (ROS) generation, and relatively high photothermal conversion efficiency (PCE) of 51.9%. In vitro and in vivo experiments demonstrated that positive-charged STB not only can actively target the mitochondria of tumor cells but also displayed strong antitumor effects and excellent in vivo imaging ability. This work subtly established a win-win strategy by π bridge engineering, breaking the barrier of making a balance between ROS generation and photothermal conversion, boosting a dual enhancement of PDT and PTT performance, and stimulating the development of multimodal imaging-guided precise cancer phototherapy.
- 1 November 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (21) , 21553-21566
π Bridge Engineering-Boosted Dual Enhancement of Type-I Photodynamic and Photothermal Performance for Mitochondria-Targeting Multimodal Phototheranostics of Tumor
Designing mitochondria-targeting phototheranostic agents (PTAs), which can simultaneously possess exceptional and balanced type-I photodynamic therapy (PDT) and photothermal therapy (PTT) performance, still remains challenging. Herein, benzene, furan, and thiophene were utilized as π bridges to develop multifunctional PTAs. STB with thiophene as a π bridge, in particular, benefiting from stronger donor-accepter (D-A) interactions, reduced the singlet-triplet energy gap (ΔES1-T1), allowed more free intramolecular rotation, and exhibited outstanding near-infrared (NIR) emission, effective type-I reactive oxygen species (ROS) generation, and relatively high photothermal conversion efficiency (PCE) of 51.9%. In vitro and in vivo experiments demonstrated that positive-charged STB not only can actively target the mitochondria of tumor cells but also displayed strong antitumor effects and excellent in vivo imaging ability. This work subtly established a win-win strategy by π bridge engineering, breaking the barrier of making a balance between ROS generation and photothermal conversion, boosting a dual enhancement of PDT and PTT performance, and stimulating the development of multimodal imaging-guided precise cancer phototherapy.
- 30 October 2023
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 23 (21) , 10034-10043
Sodium Citrate Nanoparticles Induce Dual-Path Pyroptosis for Enhanced Antitumor Immunotherapy through Synergistic Ion Overload and Metabolic Disturbance
Metabolic reprogramming, as one of the characteristics of cancer, is associated with tumorigenesis, growth, or migration, and the modulation of metabolic pathways has emerged as a novel approach for cancer therapy. However, the conventional metabolism-mediated apoptosis process in tumor cells exhibits limited immunogenicity and inadequate activation of antitumor immunity. Herein, phospholipid-coated sodium citrate nanoparticles (PSCT NPs) are successfully prepared, which dissolve in tumor cells and then release significant amounts of citrate ions and Na+ ions. Massive quantities of ions lead to increased intracellular osmotic pressure, which activates the caspase-1/gasdermin D (GSDMD) mediated pyroptosis pathway. Simultaneously, citrate induces activation of the caspase-8/gasdermin C (GSDMC) pathway. The combined action of these two pathways synergistically causes intense pyroptosis, exhibiting remarkable antitumor immune responses and tumor growth inhibition. This discovery provides new insight into the potential of nanomaterials in modulating metabolism and altering cell death patterns to enhance antitumor immunotherapy.
- 30 October 2023
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 23 (21) , 10034-10043
Sodium Citrate Nanoparticles Induce Dual-Path Pyroptosis for Enhanced Antitumor Immunotherapy through Synergistic Ion Overload and Metabolic Disturbance
Metabolic reprogramming, as one of the characteristics of cancer, is associated with tumorigenesis, growth, or migration, and the modulation of metabolic pathways has emerged as a novel approach for cancer therapy. However, the conventional metabolism-mediated apoptosis process in tumor cells exhibits limited immunogenicity and inadequate activation of antitumor immunity. Herein, phospholipid-coated sodium citrate nanoparticles (PSCT NPs) are successfully prepared, which dissolve in tumor cells and then release significant amounts of citrate ions and Na+ ions. Massive quantities of ions lead to increased intracellular osmotic pressure, which activates the caspase-1/gasdermin D (GSDMD) mediated pyroptosis pathway. Simultaneously, citrate induces activation of the caspase-8/gasdermin C (GSDMC) pathway. The combined action of these two pathways synergistically causes intense pyroptosis, exhibiting remarkable antitumor immune responses and tumor growth inhibition. This discovery provides new insight into the potential of nanomaterials in modulating metabolism and altering cell death patterns to enhance antitumor immunotherapy.